跳至主要内容
临床试验/NCT07326514
NCT07326514尚未招募不适用

Electronic Real-Time Heart Team Decision-making vs. Usual Care in Patients With Triple-Vessel Coronary Artery Disease and Diabetes Mellitus

China National Center for Cardiovascular Diseases0 个研究点目标入组 1,350 人开始时间: 2026年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
1,350
主要终点
One-year composite of major adverse cardiac and cerebral events

研究概览

简要总结

This is a multi-center randomized controlled trial involving patients with 3-vessel coronary artery disease and diabetes mellitus. Enrolled patients will be dividing into real-time heart team decision-making group (intervention group) and usual care group (control group). The intervention group will conduct a real-time online multidisciplinary heart team discussion and decision-making during coronary angiography. The control group will conduct an usual care decision-making.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • (Fulfill 1,2,3 or 1,4):
  • Age ≥ 18 years;
  • Diabetes mellitus;
  • Three-vessel coronary artery disease (≥70% stenosis in the left anterior descending artery, circumflex artery, and right coronary artery system);
  • Patients who required heart team discussion judging by the interventional cardiologist.

排除标准

  • Prior PCI or CABG;
  • Acute myocardial infarction with ECG and biomarker tests indicating acute phase;
  • Concurrent severe valvular heart disease, large vessel disease, or giant ventricular aneurysm requiring surgical intervention;
  • Concurrent atrial fibrillation or severe arrhythmia;
  • Other emergency admissions where elective revascularization is contraindicated;
  • Refusal or rejection of a specific treatment options (PCI or CABG);
  • Refusal to participate in the study.

结局指标

主要结局

One-year composite of major adverse cardiac and cerebral events

时间窗: 1 year

One-year composite pf all-cause mortality, myocardial infarction, stroke, repeat revascularization, and rehospitalization for recurrent angina.

次要结局

  • Percutaneous coronary intervention (PCI) utilization rate(During index hospitalization (typically within 30 days of admission))
  • Medical costs(Index hospitalization until discharge (typically within 30 days of admission).)
  • Coronary artery bypass grafting (CABG) utilization rate(During index hospitalization (typically within 30 days of admission))
  • Medical therapy rate(During index hospitalization (typically within 30 days of admission))
  • Waiting time from diagnostic angiography to treatment initiation(During index hospitalization (typically within 30 days of admission))
  • Hospital length of stay(From hospital admission to discharge for the index hospitalization (up to 30 days).)
  • Prolonged PCI hospitalization(From index PCI procedure to discharge for the index hospitalization (up to 30 days).)
  • Time spent per heart team case(At the time of the heart team discussion during the index hospitalization (up to 30 days from admission).)
  • Specialist satisfaction with discussion adequacy(Immediately after each heart team discussion during the index hospitalization (up to 30 days from admission).)
  • Seniority of participating specialist in heart team discussions(From index PCI procedure to discharge for the index hospitalization (up to 30 days))
  • Multidisciplinary synchronous shared decision-making(From index PCI procedure to discharge for the index hospitalization (up to 30 days))
  • Patient satisfaction with the decision-making process(Within 24 hours before discharge from the index hospitalization (up to 30 days from admission).)
  • Recatheterization rate(During index hospitalization (typically within 30 days of admission))
  • Specialist workload(During index hospitalization (typically within 30 days of admission))
  • Real-time consultation response rate(During index hospitalization (typically within 30 days of admission))
  • Clinical adverse events(From randomization through 1-year follow-up (events recorded during index hospitalization and at follow-up visits up to 12 months).)
  • Guideline-concordant revascularization decision rate(During index hospitalization (typically within 30 days of admission))

研究者

发起方
China National Center for Cardiovascular Diseases
申办方类型
Other Gov
责任方
Sponsor

相似试验